Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 2, 2013, Pages 159-165

  Peleg, Aviva ^a,b   Ghanim, Diab ^a   Vered, Shiraz ^c   Hasin, Yonathan ^a,b  

^a BARUCH PADEH MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Acute coronary syndrome; brain natriuretic peptide; cardiovascular biomarker; corin

Indexed keywords

ACUTE CORONARY SYNDROME; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR BIOMARKER; CORIN;

ACUTE CORONARY SYNDROME; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REGRESSION ANALYSIS; RISK FACTORS; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME;

EID: 84887615760     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613483588     Document Type: Article

References (23)

1. Battistoni A, Rubattu S and Volpe M. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol 2012; 157: 160–168.
2. Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007; 53: 552–574.
3. Burnett JC Jr. Novel therapeutic directions for the natriuretic peptides in cardiovascular disease: what's on the horizon? Cardiology 2006; 48: 235–241.
4. Munagala VK, Burnett JC Jr and Redfield MM. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol 2004; 29: 769–707.
5. Daniels LB and Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357–2368.
6. Dries DL. Process matters: emerging concepts underlying impaired natriuretic peptide system function in heart failure. Circ Heart Fail 2011; 4: 107–110.
7. Eggers KM, Lagerqvist B, Venge P, et al. Prognostic value of biomarkers during and after non–ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2009; 54: 357–364.
8. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004; 110: 128–134.
9. O'Connor RE, Brady W, Brooks SC, et al. Part 10: acute coronary syndromes: 2010 American association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010; 122: S787–S817.
10. Jiang J, Wu S, Wang W, et al. Ectoderm shedding and autocleavage of the cardiac membrane protease corin. J Bio Chem 2011; 286: 10066–10072.
11. Huntley BK, Heublein DM and Burnett JC Jr. Corin expression in specific human cardiac endothelial cells and cardiac fibroblasts. J Cardiology Failure 2003; 9: S41.
12. Yan W, Wu F, Morser J, et al. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide–converting enzyme. Proc Natl Acad Sci USA 2000; 97: 8525–8529.
13. Semenov AG, Tamm NN, Seferian KR, et al. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertase. Clin Chem 2010; 56: 1166–1176.
14. Wang W, Liao X, Fukuda K, et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circulation Res 2008; 103: 502–508.
15. Chen S, Sen S, Young D, et al. Protease corin expression and activity in failing hearts. Am J Physiol Heart Circ Physiol 2010; 299: H1687–9H1682.
16. Wu Q. The serine protease corin in cardiovascular biology and disease. Front Biosci 2007; 12: 4179–4190.
17. Dong N, Chen S, Yang J, et al. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010; 3: 207–211.
18. Peleg A, Jaffe AS and Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clin Chim Acta 2009; 409: 85–89.
19. Ichiki T, Huntly BK, Heublein DM, et al. Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation. Clin Chem 2011; 57: 40–47.
20. Ibebuogu UN, Gladysheva IN, Houng AK, et al. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide. Circ Heart Fail 2011; 4: 114–120.
21. Dong N, Chen S, Wang W, et al. Corin in laboratory diagnostics. Clin Chim Acta 2012; 413: 378–383.
22. Chang AY, Shuaib AM, Tulika J, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 2007; 49: 109–116.
23. Redfield MM, Rodeheffer RJ, Jacobson SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40: 976–982.